Core Points - President Donald Trump's decision to relax federal marijuana regulations has been positively received by the US cannabis industry, indicating a potential shift in federal policy towards cannabis [1] - Despite the regulatory changes, the cannabis sector continues to face significant challenges, particularly in accessing mainstream financial services and banking [1] Industry Summary - The US cannabis industry is experiencing a moment of optimism due to the relaxation of federal regulations, which may lead to increased investment and growth opportunities [1] - Access to traditional banking and financial services remains a critical issue for the cannabis sector, hindering its ability to operate on par with other industries [1]

Breaking news. It hasn't even been two hours since President Trump signed an executive order reclassifying marijuana. And the pot adjacent play, Scott's Miracle Grow, is making news regarding its Hawthorne subsidiary that sells cannabis growing supplies such as light systems and plant nutrients to marijuana growers.Scots talking about its plan to combine that subsidiary with a dedicated Pure Play cannabis company next year. Well, right there in the room, Scott's Miracle Grow CEO Jim Hagadorn was with the pr ...

Core Viewpoint - President Donald Trump's executive order marks a significant shift in federal cannabis policy, directing federal agencies to loosen regulations on marijuana [1] Regulatory Changes - The order instructs U.S. Attorney General Pam Bondi to expedite the rescheduling of marijuana to Schedule III under the Controlled Substances Act, aligning it with common painkillers but not fully legalizing it [2] - Marijuana's current classification as a Schedule I substance has limited research opportunities, and reclassification aims to enhance studies on safety and effectiveness, particularly for vulnerable populations [4] Access to CBD Products - The order outlines steps to improve access to hemp-derived cannabinoid products, especially cannabidiol (CBD), which currently lacks a clear regulatory pathway through the FDA [5] - It directs the White House Deputy Chief of Staff to collaborate with Congress to expand access to full-spectrum CBD products while restricting those posing health risks [6] Political Reactions - Senate Minority Leader Chuck Schumer supports the order, viewing it as a positive step, but emphasizes the need for further decriminalization and easing banking regulations for the cannabis industry [7] - Conversely, some Republican senators, including Ted Budd, criticize the order as shortsighted and potentially harmful to youth [7][8] Market Reactions - Cannabis stocks initially surged following the announcement but retreated by the close, attributed to the lack of expected cannabis banking provisions in the order [9] - Despite the retreat, major cannabis stocks have seen significant gains throughout the month in anticipation of the executive order [11]

Core Viewpoint - U.S. President Donald Trump's decision to relax marijuana regulations may alleviate some challenges for cannabis companies, but it is unlikely to improve their access to capital from major banks [1] Group 1 - The relaxation of marijuana regulations could reduce operational burdens for cannabis companies [1] - Experts suggest that despite regulatory changes, access to capital from big banks will remain restricted for the cannabis industry [1]

Core Insights - The recent executive order by President Trump marks a significant step in cannabis policy reform, although it does not legalize cannabis, it facilitates medical research and alleviates the tax burden on companies in the industry [1][2] - The executive order is seen as a precursor to further legislative actions, particularly regarding safer banking for cannabis businesses, which could lead to greater access to capital and potential listings on major US exchanges like NASDAQ and NYSE [3][4] Industry Impact - The cannabis industry has faced significant challenges, including a 20% market sell-off following a 150% increase in five days, indicating volatility and market reactions to news [5] - There is a concern regarding the relationship between the cannabis and hemp markets, particularly in light of the new regulations and the need for a regulated marketplace [5][6] - The executive order emphasizes the importance of safe, regulated, and tested products, aligning with the existing medical cannabis programs in 40 states [7][8]

Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The news team covers medium and small-cap markets, as well as blue-chip companies, commodities, and broader investment stories [3] - Proactive has bureaus and studios in key finance and investing hubs including London, New York, Toronto, Vancouver, Sydney, and Perth [2] Group 2 - The company is focused on sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] - Proactive adopts technology to enhance workflows and improve content production [4] - All content published by Proactive is edited and authored by humans, ensuring adherence to best practices in content production and search engine optimization [5]

Core Points - Cannabis has been rescheduled from a Class 1 to a Class 3 substance under the Controlled Substances Act, marking a significant reform in its legal status [1][2] - The new law will enable the IRS to collaborate with legal cannabis businesses, providing them with tax breaks and incentives [1] - The bill aims to enhance cannabis research and redefine hemp to ensure full-spectrum CBD is accessible to patients [2] Industry Impact - The rescheduling is seen as a win for corporate cannabis, but it may pose challenges for smaller craft cannabis operators, potentially disrupting the coexistence of mom-and-pop brands in the industry [5] - Initial reactions in the marijuana stock market were muted, but there is potential for increased trading activity as investors fully digest the news [5] - The cannabis sector may experience a rise in stock prices as the week closes, depending on investor sentiment [5]

President Donald Trump signed an executive order on Thursday directing federal agencies to reclassify marijuana from Schedule I to Schedule III. The move sent US cannabis stocks sharply higher on expe... ...

Core Viewpoint - The president has signed an executive order to reclassify marijuana from a Schedule I drug to a Schedule III drug, indicating a shift towards less regulation and acknowledging the therapeutic potential of marijuana, particularly for patients with serious illnesses like cancer [1][2]. Industry Impact - The reclassification of marijuana is expected to have significant implications for the cannabis industry, potentially leading to increased investment and market activity as stocks have already begun to move positively in anticipation of this change [2]. Market Reaction - Following the announcement of the reclassification, cannabis stocks have been on the rise for about a week, indicating strong market interest and investor confidence in the sector's future prospects [2].

Core Point - The order being signed does not legalize marijuana or sanction its use as a recreational drug, emphasizing that it is not related to future legalization efforts [1] Group 1 - The statement highlights the distinction between the order and the legalization of marijuana, clarifying that it does not endorse recreational use [1]